CS237741B1 - Ethylene-N, N'-bis-leucine and its method of preparation - Google Patents
Ethylene-N, N'-bis-leucine and its method of preparation Download PDFInfo
- Publication number
- CS237741B1 CS237741B1 CS1010083A CS1010083A CS237741B1 CS 237741 B1 CS237741 B1 CS 237741B1 CS 1010083 A CS1010083 A CS 1010083A CS 1010083 A CS1010083 A CS 1010083A CS 237741 B1 CS237741 B1 CS 237741B1
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- ethylene
- leucine
- bis
- aqueous solution
- aqueous
- Prior art date
Links
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Etylén-N,N'-bis-leucin, všeobecného vzorca I CH, CHí CH-CH2-CH-C00H NH Wn (I) CH, NH I CH-CH2-CH-C00H kde n = 2, sa připravuje kondenzáciou leucinu s etyléndibromidom v alkelickom prostředí ze refluxu a tlaku 105 až 5.10° Pa v molárnom pomere leucin k etyléndibrom 2:1 až 5:1 θ produkt sa izoluje okyslením reakčnej zmesi anorganickou kyselinou. Etylén-Ν,Ν -bis-leuoin možno využiť ako selektívne detoxifikačné činidlo v zdravotníctve.Ethylene-N,N'-bis-leucine, of the general formula I CH, CHí CH-CH2-CH-C00H NH Wn (I) CH, NH I CH-CH2-CH-C00H where n = 2, is prepared by condensation of leucine with ethylene dibromide in an alkaline environment from reflux and a pressure of 105 to 5.10° Pa in a molar ratio of leucine to ethylene dibromide of 2:1 to 5:1 θ the product is isolated by acidifying the reaction mixture with an inorganic acid. Ethylene-Ν,Ν -bis-leuoin can be used as a selective detoxifying agent in healthcare.
Description
Vynález aa týká etylén-N,N'-bis-leucinu a spfisobu jeho přípravy.The invention aa relates to ethylene-N,N'-bis-leucine and its preparation.
Etylén-N,N'-bis-leueíny sú nová komplexony na báze prírodnej aminokyseliny leuoinu. Ide o novo syntetizované látky, v literatúre doposial’ nepopísaná. V patentovéj literatúre sa sice nachádzajú údaje o kondenzácii niektorých nižších aminokyselin, například Britský patent í. 732 316, ale tento postup má nevýhodu v tom, že sa jedná o tlakový proces a výtažky reakcie sú značné nízké.Ethylene-N,N'-bis-leuines are new complexones based on the natural amino acid leuine. They are newly synthesized substances, not yet described in the literature. Although there are data in the patent literature on the condensation of some lower amino acids, for example British patent No. 732 316, this procedure has the disadvantage that it is a pressure process and the reaction yields are considerably low.
Dosieí známe deriváty tohto typu msjú nižšiu selektivitu a stereošpecifieitu. Uvedené nedostatky sú odstránené vynálezom, ktorého podstatou sú nové komplexony etylén-H,N'-bis-leucinoV všeobecného vzorca IPreviously known derivatives of this type have lower selectivity and stereospecificity. The above-mentioned shortcomings are eliminated by the invention, the essence of which is the new ethylene-H,N'-bis-leucine complexones of the general formula I
kde n = 2.where n = 2.
Podstatou spfisobu přípravy etylén Ν,Ν'-bis-leueínov je, že sa vo vodnom roztoku, připadne vodno-alkoholickom prostředí leucín nechá kondenzovat s etyléndibromidom v alkalickom prostředí za refluxu a tlaku ItP až 5.10^ Pa v molárnom pomere leucín ku etyléndibromid 2:1 až 5:‘1, výhodné 2:1 až 3:2. Kondenzécia leucínu s etyléndibromidom prebieha podl'a rovnice:The essence of the method for preparing ethylene N,N'-bis-leuines is that in an aqueous solution or in an aqueous-alcoholic medium, leucine is allowed to condense with ethylene dibromide in an alkaline medium under reflux and a pressure of ItP to 5.10^ Pa in a molar ratio of leucine to ethylene dibromide of 2:1 to 5:'1, preferably 2:1 to 3:2. The condensation of leucine with ethylene dibromide proceeds according to the equation:
CH, 'CH.CH, 'CH.
CHÍCHI
3CHCH2jHCOOH + X(CH2)nX3CHCH 2 jHCOOH + X(CH 2 ) n X
NH, /NH, /
6^36^3
3 13 1
CH-CH,-CH=COOH + 2ΗΧ (I), wn CH-CH,-CH=COOH + 2ΗΧ (I), w n
CH3 \CH 3 \
zfrom
CH,CH,
CHNHCHNH
I ch2-ch-cooh kdeI ch 2 -ch-cooh where
X = bróm a n = 2.X = bromine and n = 2.
Pri reakcii vzniká etylén Ν,Ν'-bis-leueín a bromovodík, ktorý sa výhodné viaže pridavkom alkálií vo formě příslušného halogenidu alkalického kovu, čím se priebeh reakcie posúva doprava, čo je priaznivé pre vznik etylén-M,N'-bis-leucínov.The reaction produces ethylene N,N'-bis-leuine and hydrogen bromide, which is advantageously bound by the addition of alkali in the form of the appropriate alkali metal halide, thereby shifting the reaction course to the right, which is favorable for the formation of ethylene-N,N'-bis-leucines.
Kondenzácia vo vodnom prostředí se vykonává zmiešaním vodné j suspenzie leucínu s etylándibromldom s vodným, vodno-alkoholickým alebo alkoholickým roztokom hydroxidu alkalického kovu. Rovnako výhodné je použitie tuhého uhličitanu alebo hydrogénuhličitanu alkalického kovu alebo kovov alkalických zemin.The aqueous condensation is carried out by mixing an aqueous suspension of leucine with ethylene dibromide with an aqueous, aqueous-alcoholic or alcoholic solution of an alkali metal hydroxide. It is also preferred to use a solid carbonate or bicarbonate of an alkali metal or alkaline earth metal.
Roztok sa za miešania refluxuje niekoTko hodin. Po ochladení roztoku a okyslení anorganickou kyselinou, například koncentrovanou kyselinou chlorovodíkovou sa vylúči surový etylén Ν,Ν'-bis-leucín, ktorý sa niekoTkokrát prekryštalizuje z horúcej vody alebo zmesi voda a etanol, alebo sa čistí spatným převedením na soT alkalického kovu alebo kovu alkalických zemin a opatovným vyzrážaním anorganickou kyselinou.The solution is refluxed with stirring for several hours. After cooling the solution and acidifying with an inorganic acid, for example concentrated hydrochloric acid, crude ethylene N,N'-bis-leucine is separated, which is recrystallized several times from hot water or a mixture of water and ethanol, or purified by conversion back to an alkali metal or alkaline earth metal salt and reprecipitation with an inorganic acid.
Výhodou přípravy etylén N,N*-bis-leuoínov podTa vynálezu je, že kondenzácie preblehe dostatočne rýchle už za atmosférického tlaku a s vyššími výťažkemi než pri postupoch popísanýeh vo vyššieuvedenom patente.The advantage of preparing ethylene N,N*-bis-leucines according to the invention is that the condensations proceed sufficiently rapidly even at atmospheric pressure and with higher yields than in the processes described in the above-mentioned patent.
PříkladExample
V 250 ml trojhrdlej banke opatrenej miešadlom, spatným chladičom a prikvapkávacou nálevkou sa 20 g (0,5 mol) hydroxidu sodného v 40 ml vody přidává 65,6 g (0,5 mál) L-leuoinu. Roztok sa za miešania zahřeje na reflux a 47 g (0,25 mál) etyléndibromidu spolu s 34,5 g (0,25 mál) uhličitanu draselného sa pomaly přidává tak, aby pH roztoku bolo 11 až 12. Po přidaní celého množstva etyléndibromidu sa roztok za miešania nechá ešte 30 hodin refluxovať.In a 250 ml three-necked flask equipped with a stirrer, reflux condenser and dropping funnel, 65.6 g (0.5 mol) of L-leuine are added to 20 g (0.5 mol) of sodium hydroxide in 40 ml of water. The solution is heated to reflux with stirring and 47 g (0.25 mol) of ethylene dibromide together with 34.5 g (0.25 mol) of potassium carbonate are slowly added so that the pH of the solution is 11 to 12. After the entire amount of ethylene dibromide has been added, the solution is allowed to reflux with stirring for another 30 hours.
Po ochladení a odfiltrovaní nezreagovaného uhličitanu draselného a vyléčeného bromidu draselného sa roztok okyslí koncentrovanou kyselinou chlorovodíkovou. Při pH 9 sa vylúči biely surový produkt, ktorý sa po premytí destilovanou vodou čistí rekryštalizáciou zo zmesi etanol a voda (1 + 1) alebo převedením na sodnou sol’ra opatrným vyzrážaním koncentrovanou kyselinou chlorovodíkovou pri Ph 9. ”After cooling and filtering off the unreacted potassium carbonate and the cured potassium bromide, the solution is acidified with concentrated hydrochloric acid. At pH 9, a white crude product is separated, which, after washing with distilled water, is purified by recrystallization from a mixture of ethanol and water (1 + 1) or by conversion to sodium sol’ra by careful precipitation with concentrated hydrochloric acid at Ph 9. ”
Takto sa získá 45,5 g etylén N,N'-bis-L-leucinu, čo představuje 63 %-ný výťažok. Teplo ta topenia je 280 °C. Sumárny vzorec je C^H^gN^O^. Molekulová hmotnost je 288,38. Elementárna analýza výpočtom: C = 58,31 %, H = 9,78 %, N = 9,71 %. Nájdené: C = 57,93 %,This gives 45.5 g of ethylene N,N'-bis-L-leucine, which represents a 63% yield. The melting point is 280 °C. The molecular formula is C^H^gN^O^. The molecular weight is 288.38. Elemental analysis by calculation: C = 58.31%, H = 9.78%, N = 9.71%. Found: C = 57.93%,
H = 9,64 %, N = 9,55 %. Získaná novosyntetizované látka bola ocharakterizovaná IČ a '^C-řC.IR spektroskopiou. iC spektra boli namerané KBr-technikou v oblasti 4 000 až 400 cm\ Charakteristické absorpčně pásy etylén-Ν,Ν -bis-L-leucínu sú uvedené v tabuTke 1.H = 9.64%, N = 9.55%. The newly synthesized substance obtained was characterized by IR and 13C-13C IR spectroscopy. The IR spectra were measured by KBr technique in the range of 4000 to 400 cm. The characteristic absorption bands of ethylene-Ν,Ν-bis-L-leucine are given in Table 1.
23774,4 a b u Ϊ k a 123774.4 a b u Ϊ k a 1
Charakteristické absorpčně pásy etylén-N,N'-bis-L-leucínuCharacteristic absorption bands of ethylene-N,N'-bis-L-leucine
s = silný, š = široký, str = stredný, sl = slabý, r = rameno štruktúra novej syntetizovanéj zlúčeniny bola potvrdená i ’^C-ÍCÍR spektroskopiou. Roztok etylén-N,Nx-bis-L-leucinu bol připravený s koncentráciou 10 % hmot. v NaOD (pD = 13). Ako interný Standard bol použitý 4,4-dimetyl-4 silapentansulfonan sodný (D3S). Spektrum bolo merané na pulznom spektrometr! pri pracovnej frekvenci! 25,047 MHz a rozsahu 6 000 Hz. Rezonančně frekvencie jednotlivých signálov spolu s ich priradením sú uvedené v tabuTke 2.s = strong, ś = broad, str = medium, sl = weak, r = arm The structure of the newly synthesized compound was confirmed by 13C-IR spectroscopy. A solution of ethylene-N,N x -bis-L-leucine was prepared with a concentration of 10 wt. % in NaOD (pD = 13). Sodium 4,4-dimethyl-4 silapentanesulfonate (D3S) was used as an internal standard. The spectrum was measured on a pulse spectrometer at a working frequency of 25.047 MHz and a range of 6,000 Hz. The resonance frequencies of the individual signals together with their assignments are given in Table 2.
Tabulka 2 '^C-NMR spektrálné údaje etylén-N,N'-bis-L-leucinovTable 2 '^C-NMR spectral data of ethylene-N,N'-bis-L-leucines
Komplexy přechodných kovov a samotné komplexony tohto typu je možné využit ako selektívne detoxifikačné činidlá v zdravotníctve.Transition metal complexes and complexones of this type themselves can be used as selective detoxification agents in healthcare.
Claims (4)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS1010083A CS237741B1 (en) | 1983-12-29 | 1983-12-29 | Ethylene-N, N'-bis-leucine and its method of preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS1010083A CS237741B1 (en) | 1983-12-29 | 1983-12-29 | Ethylene-N, N'-bis-leucine and its method of preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS237741B1 true CS237741B1 (en) | 1985-10-16 |
Family
ID=5447953
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS1010083A CS237741B1 (en) | 1983-12-29 | 1983-12-29 | Ethylene-N, N'-bis-leucine and its method of preparation |
Country Status (1)
| Country | Link |
|---|---|
| CS (1) | CS237741B1 (en) |
-
1983
- 1983-12-29 CS CS1010083A patent/CS237741B1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2397173C2 (en) | Crystalline morphinan derivatives and synthesis method thereof | |
| PL179578B1 (en) | Method for the production of 5-acetamido-2,3,4,5-tetradeoxy-4-guanidine-D-glycero-D-galacto-non-2-enopyranosonic acid PL | |
| CS237741B1 (en) | Ethylene-N, N'-bis-leucine and its method of preparation | |
| JP4718444B2 (en) | Protein-binding derivatives of platinum complexes having cyclobutane-1,1-dicarboxylate ligands | |
| MC940A1 (en) | Method for preparing n- (1-ethyl-pyrrolidylmethyl) -2-methoxy-5-sulfamidobenzamide | |
| JPH02225475A (en) | Preparation of pyrimidine derivative | |
| CS202432B1 (en) | Method of preparing ethylene-n,n-bis-valine | |
| SU690002A1 (en) | Method of preparing 4-methoxy-1,2-naphthoquinone | |
| JP3859093B2 (en) | Method for producing antitumor platinum complex carboplatin | |
| RU2225866C1 (en) | Acetic acid potassium salt eliciting cardiotonic activity | |
| RU2213092C2 (en) | Method for preparing substituted symm-octahydroselenoxanthenes | |
| SU1089085A1 (en) | Process for preparing allylamine | |
| SU1657495A1 (en) | Method for obtaining 3-ciano-4-methyl-5-chloro-6-hydroxypyridone- 2 | |
| CS276922B6 (en) | 3-Aidomethyl-4-hydroxyphenylalkylthetones and their preparation | |
| JPS59175467A (en) | Ureidobenzamide derivative | |
| SU391141A1 (en) | ||
| Wood et al. | CXI.—The constitution of the salts of barbituric acid | |
| RU2143419C1 (en) | Method of preparing 2,2'-dichlorodiethylformal | |
| US3262945A (en) | N-(4-propyl-l-hygroyl) lincosamine phenylosazone | |
| JPH05170729A (en) | Preparation of 3'-aminopropyl-2-chloroethylsulfone semisulfate | |
| SU1109410A1 (en) | Process for preparing n-alkyl-n-(beta-d-glycosyl)-n-nitroso urea | |
| SU1159920A1 (en) | Method of obtaining 2-(2'-oxy-5'-methylphenyl)-0-benztriazole | |
| SU502603A3 (en) | The method of obtaining derivatives diphenylaminopropane | |
| CN114763334A (en) | Levetiracetam 3-site isomer impurity and preparation method thereof | |
| SU857114A1 (en) | Method of preparing n-phenyl-substituted glycins |